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AllergyA case study is reported whereby an individual with known sulﬁte and sulfonamide allergies develops
hypersensitivity to taurine above a threshold level as well as to the non-nutritive sweetener acesulfame
potassium, compounds that are not normally associated with allergic reactions. Sulﬁtes, sulfonamides,
taurine and acesulfame potassium all contain a SO3 moiety. Challenge tests provide evidence for the
hypersensitivities to taurine and acesulfame potassium. The subject is also allergic to thiuram mix and
thimerosal, sulfur containing compounds, as well as to various food products. This may be the ﬁrst case
where hypersensitivities to taurine and acesulfame potassium have been documented and reported.
Several mechanistic explanations are provided for the untoward reactions to taurine and acesulfame
potassium.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license.1. Introduction
Allergic reactions are known to occur to sulfur-containing com-
pounds such as sulﬁtes (Fig. 1) (sulfur dioxide, bisulﬁtes and meta-
bisulﬁtes), antibiotic sulfonamides (Fig. 2) as sulfamethoxazole,
non-antibiotic sulfonamides as furosemide and thiazides, other
sulfur-containing drugs as omeprazole, thiuram-containing drugs
as disulﬁram (Fig. 3), and various sulfur-containing compounds
in foods. However, the extent to which cross-reactivity occurs
between various sulfur-containing compounds remains unclear
(Slatore and Tilles, 2004). An examination of cross-reactivity based
on case reports and articles concluded that ‘‘the level of evidence in
many cases does not conclusively support either a connection or an
association between observed cause and effect’’ (Johnson et al.,
2005).
Although the FDA has banned the use of sulﬁtes on fruits and
vegetables as a means of retaining freshness and to prevent micro-
bial growth, sulﬁtes still can be found in cooked and processed
foods, and occur naturally in beers and wines (http://www.web-
md.com/allergies/guide/sulﬁte). Furthermore, allergies to sulﬁtes
can occur at any time in life, the trigger for the sensitivity is gener-ally unknown, and sulﬁtes may be tolerated up to a threshold
amount (Timbo et al., 2004).
The FDA estimates that about one percent of people in the Uni-
ted States are sulﬁte hypersensitive, and ﬁve percent of these peo-
ple are asthmatic. Adverse clinical effects associated with sulﬁte
exposure range from ﬂushing, dermatitis, urticaria, hypotension
and diarrhea to life-threatening anaphylactic and asthmatic reac-
tions (Vally et al., 2009).
We report a case study where a subject has a history of hyper-
sensitivity reactions to a variety of sulfur-containing ingredients,
including sulﬁte associated with wine, the non-nutritive sweetener
acesulfame potassium (Fig. 4), taurine (Fig. 5) at above certain
amounts, sulfonamides, and various foods associated, presumably,
with sulfur-containing compounds. Acesulfame is an organic
chemical with an embedded sulﬁte (SO3) moiety. Taurine or 2-ami-
noethanesulfonic acid is a widely distributed amino acid that
contains a sulfonic acid (sulﬁte, SO3) group rather than carboxylic
acid group. In some cases, challenge tests were performed to verify
and identify the offending ingredient.
2. Background
The subject is a physically ﬁt, petite female who exercises reg-
ularly, weighs 47.7 kg (105 lbs), is 1.55 m (61 inches) tall, and at
the time of this writing, is over 40 years old. She typically exercises
5 days a week, running 3–4 miles three times a week. She consid-
ers herself a healthy eater who avoids reﬁned sugars, fried and
fatty foods, bread and dairy. She has a known history of allergic
reactions to various foods, including shellﬁsh, corned beef (two
Fig. 1. Sulﬁte.
Fig. 2. Sulfonamides.
Fig. 3. Disulﬁram.
Fig. 4. Acesulfame potassium.
Fig. 5. Taurine.
Table 1
Products used by subject.
Product Product description Sulfur-containing Ingredient
(s)
A Amino acid supplement capsule 50 mg taurine
B Energy drink 200 mg taurine
C Energy and weight management
tablet
300 mg taurine
D Performance and recovery drink 500 mg taurine
E ATP-generating energy drink 135 mg acesulfame potassium
F Rehydration and energy drink 29 mg acesulfame potassium
G Rehydration drink None
H Rehydration gel None
I Vitamin-mineral energy drink None
J Metabolic stimulant capsule None
K Multivitamin/mineral tablet Methionine + amino acids
L Vitamin D/mineral tablet Methionine + amino acids
M Omega-3 fatty acid gelcap None
N Women’s health herbal capsule None
O Meal replacement shake 24 g Protein
P Protein shake 25 g Protein
Q After workout recovery shake 12 g Protein + 250 mg DL-
methionine
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avocados (extreme abdominal pain and swelling), and tree nuts
(one reaction involving swelling of lips, face, and hands and difﬁ-
culty breathing). She has no history of asthma.
The subject experiences red wine headaches with sinus conges-
tion which may be related to sulﬁte content. Food intolerance
patch testing indicated moderate hypersensitivity to soybeans
and wheat. She also has a documented history of allergic reactions
to sulfonamide drugs. The products used by the subject are listed
in Table 1.
As part of her ﬁtness program, the subject began using a capsule
product containing the branched chain amino acids L-leucine, L-ly-
sine and L-isoleucine plus glutamine and 50 mg taurine (Product
A). Use of the product alone several times a day resulted in no
adverse effects. However, when combined with an energy drink
that contained 200 mg taurine, 120 mg caffeine, 200 mg L-tyrosine,
and B vitamins with sucralose as the non-nutritive sweetener
(Product B), she noticed that she would experience a tingling sen-
sation in her lips and face and a feeling of fullness in her sinuses.
On one occasion, the subject took the products immediately
before running 3 miles, whereupon she experienced a reactionresulting in hypotension, itching and swelling of her mouth, lips
and throat with welts under the eyes. She immediately went to
an urgent care facility and received an epinephrine injection. She
stopped taking the two products. She had also been taking a
combination energy and weight management product that con-
tained a variety of ingredients including 300 mg taurine, caffeine,
B vitamins, and Coleus forskolii (Product C). She continued taking
this product but began experiencing the tingling sensation in her
lips and mouth, tightening of the throat and fullness in her sinuses.
She therefore discontinued taking Product C.
After being off the above three products for approximately a
week, she took a single dose of a performance and recovery drink
product that contained the branched chain amino acids, 500 mg
taurine, quercetin, B vitamins and cats claw extract (Product D).
Within 2 h she had an allergic reaction that required medical
attention. The only ingredient in these four products in common
was taurine.
After refraining from using the above four products for approx-
imately four weeks, the subject used the capsule product contain-
ing the branched chain amino acids with the 50 mg taurine twice a
day (Product A) without event for a week with no adverse effects.
She then added the energy/weight management tablets that con-
tained 300 mg taurine (Product C) and promptly had an allergic
and hypotensive reaction that required use of an EpiPen. She
immediately discontinued use of all of the above products.
The subject subsequently took a sports performance drink prod-
uct that contains Kreb cycle intermediates as an energy source and
ATP generating system (Product E). The product contained no
sulfur-containing amino acids or other sulfur-containing ingredi-
ents with the exception of acesulfame potassium (135 mg) as a
non-nutritive sweetener. She experienced her usual symptoms
including lip and facial swelling, sinus congestion and difﬁculty
breathing, indicative of an allergic reaction. She subsequently used
another rehydration and energy ﬂuid (Product F), and experienced
a less severe allergic reaction. This product also contains acesul-
fame potassium (29 mg/0.5 L) as the non-nutritive sweetener with
no other sulfur-containing ingredients.
In order to further test the hypothesis that the subject had a
hypersensitivity or allergy to various sulfur-containing compounds
as acesulfame potassium and taurine, she repeatedly used both a
rehydration drink (Product G) and a rehydration gel (Product H)
that contained no sulfur-containing ingredients, and she did not
experience an adverse reaction. The rehydration products con-
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non-sulfur containing amino acids and sucralose as the non-nutri-
tive sweetener. She also repeatedly used a vitamin-mineral-adap-
togen energy drink (Product I) and a capsule energy and weight
management product that contained sage extract, oolong tea ex-
tract, B vitamins and 45 mg caffeine (Product J). None of these four
products included sulfur-containing ingredients, and she experi-
enced no allergic or sensitivity reactions.
The subject currently uses on a daily basis without adverse ef-
fects a vitamin-mineral caplet product (Product K), a vitamin D-
mineral tablet product (Product L), an omega-3 fatty acid gelcap
product (Product M), an herbal women’s health product containing
extracts of maca, Tinospora, Asparagus and Withania (Product N),
the metabolic stimulant capsule (Product J), and the branched
chain amino acid supplement with 50 mg taurine (Product A) twice
daily. The vitamin-mineral product (Product K) contains mg
amounts of complexes of the sulfur-containing amino acid methi-
onine with zinc and selenium. In addition, it contains amino acid
complexes of copper, manganese, molybdenum, magnesium,
potassium and phosphorus which may possess trace amounts of
sulfur-containing amino acids. The vitamin D-mineral product
(Product L) also contains zinc methionine as well as amino acid
chelates of magnesium, boron, copper, manganese and silicon.
She also uses regularly a meal replacement shake (Product O) or
a protein shake (Product P), and an after workout recovery shake
(Product Q) that contains 12 g protein and 250 mg DL-methionine.
The meal replacement shake and the protein shake contain no sul-
fur compounds other than the sulfur amino acids in the protein.
The subject underwent an 80 item hypersensitivity patch test
on her back and was shown to have a high sensitivity to thiuram
mix and thimerosal, both sulfur containing. The thiuram mix con-
tains the four allergens disulﬁram, tetramethylthiuram monosul-
ﬁde, tetraethylthiuram disulﬁde and dipentamethylenethiuram
disulﬁde. These chemicals are widely found in rubber products.
Tetraethylthiuram disulﬁde is a fungicide, while disulﬁram (Ant-
abuse) is a drug used for treatment of alcoholism. Thimerosal
(Merthiolate) is an organic mercury sulfur compound (organo-
mercury thiolate) used as an antiseptic and preservative.
The subject was also shown to be sensitive to methyldibromo
glutaronitrile, which is a preservative used in cosmetics and paints,
and DMDM hydantoin (1,3-dimethylol-5,5-dimethylhydantoin)
which is a preservative and formaldehyde donor used in shampoos,
skincare products, conditioners, paints, waxes and other industrial
products. She also tested sensitive to propylene glycol and potas-
sium dichromate. None of these latter four compounds are sulfur
containing.3. Discussion
The subject had a known history of hypersensitivities and aller-
gic reactions to various foods and sulfonamide antibiotics that
developed after the age of 20 years. As a consequence she carefully
avoids foods and drugs to which she is known to be allergic. She is
a ﬁtness enthusiast who exercises regularly, eats very healthfully
and uses a variety of dietary supplements to support her overall
health and physical performance.
The subject used four different dietary supplements (Products
A–D) that were associated with a hypersensitivity reaction ranging
from tingling of the lips and face to swollen lips, mouth and throat,
which required treatment with epinephrine. The primary ingredi-
ent and only sulfur-containing constituent in common was taurine,
a widely used ingredient in energy drinks and related products
(Warburton et al., 2001; Brosnan and Brosnan, 2006; Shao and
Hathcock, 2008). The amount of taurine in these products varied
from 50 mg to 500 mg per dose, and the symptoms ranged fromnon-existent at the low dose to requiring medical attention at
the high end.
These observations suggested that a threshold level of taurine
was required to produce a reaction, which is consistent with effects
reported for sulﬁte (Timbo et al., 2004). A challenge with a product
that contained 50 mg taurine (Product A) did not produce an
allergic reaction. However, when adding to this a product that con-
tained either 200 mg or 300 mg taurine (Products B, C) or using a
product by itself that contained 500 mg taurine (Product D), she
experienced an allergic reaction. The results suggest that the
threshold amount of taurine as a single dose needed to produce a
reaction was in the neighborhood of 250–300 mg.
Several possible biochemical and metabolic explanations exist
for this observed sensitivity to taurine, in spite of the fact that
taurine serves a wide variety of bodily functions and is abundant
in brain, retina, muscle tissues and organs throughout the body
(Wu and Prentice, 2010; Schaffer et al., 2010; Riggs and Shen,
2012). As previously noted, taurine contains a sulﬁte (SO3) moiety.
Multiple pathways exist for the catabolism and elimination of
taurine. One of these pathways is the conversion of taurine to
sulﬁte and aminoacetaldehyde by the enzyme taurine dioxygenase
(Grzyska et al., 2005).
If the metabolism of a bolus of taurine is shunted into producing
more sulﬁte in a sulﬁte hypersensitive individual, the threshold for
experiencing a sulﬁte reaction may be exceeded. This could occur if
the amount of taurine exceeds the metabolic rates for other cata-
bolic pathways, the subject has low or deﬁcient levels of some of
the catabolic enzymes associated with taurine, or has abnormally
high levels of the enzyme taurine dioxygenase which is involved
in the formation of sulﬁte and aminoacetaldehyde.
A second possible explanation for the observed hypersensitivity
exists. The subject was determined to be sensitive to disulﬁram
(Fig. 3) which is an irreversible inhibitor of aldehyde dehydroge-
nase, the enzyme responsible for metabolism and removal of acet-
aldehyde (Gaval-Cruz and Weinshenker, 2009). Accumulation of
acetaldehyde results in characteristic symptoms including ﬂush-
ing, headache, abdominal pain, nausea, hypotension, and hyper-
ventilation which are associated with the use of alcohol (ethanol)
in the presence of disulﬁram (Petersen, 1992; Charpeaud et al.,
2011). Some of the hypersensitivity effects may be associated with
the formation of acetaldehyde or aminoacetaldehyde in conjunc-
tion with the metabolism of taurine. Levels of acetaldehyde dehy-
drogenase may be physiologically low or low due to inhibition by
taurine or one of its metabolites, resulting in acetaldehyde accu-
mulation and the acute toxicity associated therewith. Epineprine
is the drug of choice for counteracting disulﬁram-induced acetal-
dehyde toxicity (Prancheva et al., 2010; Tummers-de Lind van
Wingaarden et al., 2013), and it was effective in treating the
subject on various occasions.
A third mechanistic explanation for the observed effects is that
this subject has a low level of one or more enzymes associated with
the metabolism of sulﬁte, resulting in the accumulation of sulﬁte
above threshold levels needed for a reaction. Finally, several of
the above proposed mechanisms may be concurrently involved,
accounting for the high degree of broad hypersensitivity.
When the subject consumed a product (Product E) that incorpo-
rated 135 mg acesulfame potassium (ace K) as the only sulfur-con-
taining ingredient, she experienced an allergic reaction. When this
product was replaced by another rehydration product (Product F)
that used 29 mg acesulfame potassium as the non-nutritive sweet-
ener and the only sulfur-containing ingredient, a less pronounced
allergic reaction again occurred. She did not experience a hyper-
sensitivity reaction when challenged with four additional products
that contained no acesulfame potassium or other sulfur-based
ingredients which included two rehydration products (Products
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stimulant capsule product (Product J).
These various challenge tests do not prove but strongly indicate
that the subject was allergic to acesulfame potassium. Structurally,
acesulfame potassium contains a sulﬁte (SO3) moiety, and the
subject has a history of hypersensitivity to (sulﬁte containing)
red wine, sulfonamides, presumeably taurine, and various foods.
It is not clear why the smaller amounts of acesulfame potassium
in the rehydration ﬂuids (Products E and F) may be equivalent to
higher amounts of taurine with respect to producing an adverse ef-
fect. The sulﬁte and nitrogen containing ring structure of acesu-
fame potassium (Fig. 4) may make it a more potent and effective
allergen at a lower threshold level in this subject. The acesulfame
potassium may be also converted more readily to the active agent
than taurine. No studies or case reports in the scientiﬁc literature
have reported or veriﬁed a case of a hypersensitivity reaction to
acesulfame potassium, although there have been anecdotal reports
thereof.
In addition, the subject uses on a daily or regular basis seven
other dietary supplements (Products K–Q) without a reaction.
Two of these products contain amino acid complexes of minerals
that may contain trace amounts of sulfur-containing amino acids
(Products K, L). They also contain low (mg) amounts of the sul-
fur-containing amino acid L-methionine complexed with zinc
and selenium. An explanation for a lack of adverse effect from
these latter two products is that the amounts of sulfur-containing
ingredients are very low. The after workout recovery shake (Prod-
uct Q) contains 250 mg DL-methionine, and metabolism to sulﬁte
or other reactive forms may be below the threshold levels needed
to produce a reaction.
As previously noted, taurine is widely distributed in the body
(Wu and Prentice, 2010; Schaffer et al., 2010; Riggs and Shen,
2012) and has become increasingly popular in dietary supple-
ments, functional foods and beverages. No observed adverse effect
level (NOAEL) and no lowest observed adverse effect level (LOAEL)
have been established for taurine due to the absence of a system-
atic pattern of adverse effects (Shao and Hathcock, 2008). These
authors note that ‘‘the evidence for the absence of adverse effects
is strong for taurine at supplemental intakes up to 3 g/day’’, and
they further indicate much higher levels ‘‘have been tested without
adverse effects and may be safe’’. Thus, evidence to date indicates a
high degree of safety for taurine at commonly used levels, with the
amounts used in the products described above being well within
the safety range.
Evidence regarding the safety of acesulfame potassium is less
clearly deﬁned. It is an FDA approved non-nutritive (non-caloric)
sweetener that is used in thousands of food and beverage products.
The acceptable daily intake of acesulfame potassium is 15 mg/kg
body weight/day. This is the maximum amount that is considered
safe for daily consumption over a lifetime based on animal toxicity
testing with a 100-fold safety factor (Bloomgarden, 2008). This
would require the average individual to consume at least 15 ace-
sulfame potassium sweetened rehydration drinks or 12 oz. soft
drinks daily to reach this level. The subject had limited exposure
to acesulfame potassium associated with the two rehydration
products consumed due to the onset of hypersensitivity reactions.
She was unaware of any prior exposure to acesulfame potassium,
although due to its widespread use in food and beverage products
exposure is very possible.
Systemic contact dermatitis is a skin condition where a person
who is cutaneously sensitized to an allergen as sulﬁte will react to
that same allergen or a cross-reacting allergen via the oral, sys-
temic route (Aquino and Mucci, 2013). Patch testing is useful in
cases of immediate reactions to sulﬁte containing ingredients assulfonamides and disulﬁram (Garcia-Gavin et al., 2012). Patch test-
ing of the subject revealed a high sensitivity to thiuram mix which
contains 4 sulfur containing compounds including disulﬁram, and
also to the sulfur containing compound thimerosal. These results
provide additional data supporting a hypersensitivity to sulﬁte
containing or yielding compounds as taurine.
4. Summary
This is an interesting case whereby an individual with multiple
allergies appears to be hypersensitive to taurine above a certain
threshold level, and to sulﬁtes and acesulfame potassium, all
chemicals that contain a SO3 moiety. Challenge tests provide evi-
dence for the sensitivities to taurine and acesulfame potassium.
In addition, the subject has a known allergy to sulfonamides as
well as a variety of food products. Tests have also shown that she
is allergic to thiuram mix and thimerosal, sulfur containing com-
pounds. This may be the ﬁrst case where hypersensitivities to tau-
rine and acesulfame potassium have been documented and
reported.
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